Report Detail

Pharma & Healthcare Global Glutamate Receptor Ionotropic NMDA 2B Market Professional Survey Report 2019

  • RnM2954130
  • |
  • 16 February, 2019
  • |
  • Global
  • |
  • 109 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Glutamate Receptor Ionotropic NMDA 2B market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Glutamate Receptor Ionotropic NMDA 2B volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glutamate Receptor Ionotropic NMDA 2B market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glutamate Receptor Ionotropic NMDA 2B in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glutamate Receptor Ionotropic NMDA 2B manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others

Segment by Application
Acute Ischemic Stroke
Autism
Brasin Ischemia
Burns
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Glutamate Receptor Ionotropic NMDA 2B

      • 1.1 Definition of Glutamate Receptor Ionotropic NMDA 2B
      • 1.2 Glutamate Receptor Ionotropic NMDA 2B Segment by Type
        • 1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 JNJ-0808
        • 1.2.3 Neu-2000
        • 1.2.4 NP-10679
        • 1.2.5 NP-11948
        • 1.2.6 Radiprodil
        • 1.2.7 Others
      • 1.3 Glutamate Receptor Ionotropic NMDA 2B Segment by Applications
        • 1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Acute Ischemic Stroke
        • 1.3.3 Autism
        • 1.3.4 Brasin Ischemia
        • 1.3.5 Burns
        • 1.3.6 Others
      • 1.4 Global Glutamate Receptor Ionotropic NMDA 2B Overall Market
        • 1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue (2014-2025)
        • 1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Production (2014-2025)
        • 1.4.3 North America Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)
        • 1.4.4 Europe Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)
        • 1.4.5 China Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)
        • 1.4.6 Japan Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)
        • 1.4.8 India Glutamate Receptor Ionotropic NMDA 2B Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B
      • 2.3 Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
      • 2.4 Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B

      3 Development and Manufacturing Plants Analysis of Glutamate Receptor Ionotropic NMDA 2B

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Glutamate Receptor Ionotropic NMDA 2B
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Glutamate Receptor Ionotropic NMDA 2B Production and Capacity Analysis
      • 4.2 Glutamate Receptor Ionotropic NMDA 2B Revenue Analysis
      • 4.3 Glutamate Receptor Ionotropic NMDA 2B Price Analysis
      • 4.4 Market Concentration Degree

      5 Glutamate Receptor Ionotropic NMDA 2B Regional Market Analysis

      • 5.1 Glutamate Receptor Ionotropic NMDA 2B Production by Regions
        • 5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Production by Regions
        • 5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Regions
      • 5.2 Glutamate Receptor Ionotropic NMDA 2B Consumption by Regions
      • 5.3 North America Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.3.2 North America Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Glutamate Receptor Ionotropic NMDA 2B Import and Export
      • 5.4 Europe Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.4.1 Europe Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.4.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Glutamate Receptor Ionotropic NMDA 2B Import and Export
      • 5.5 China Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.5.1 China Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.5.2 China Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Glutamate Receptor Ionotropic NMDA 2B Import and Export
      • 5.6 Japan Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.6.1 Japan Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.6.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Glutamate Receptor Ionotropic NMDA 2B Import and Export
      • 5.7 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.7.1 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.7.2 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Import and Export
      • 5.8 India Glutamate Receptor Ionotropic NMDA 2B Market Analysis
        • 5.8.1 India Glutamate Receptor Ionotropic NMDA 2B Production
        • 5.8.2 India Glutamate Receptor Ionotropic NMDA 2B Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Glutamate Receptor Ionotropic NMDA 2B Import and Export

      6 Glutamate Receptor Ionotropic NMDA 2B Segment Market Analysis (by Type)

      • 6.1 Global Glutamate Receptor Ionotropic NMDA 2B Production by Type
      • 6.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type
      • 6.3 Glutamate Receptor Ionotropic NMDA 2B Price by Type

      7 Glutamate Receptor Ionotropic NMDA 2B Segment Market Analysis (by Application)

      • 7.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption by Application
      • 7.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Market Share by Application (2014-2019)

      8 Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers Analysis

      • 8.1 BioCrea GmbH
        • 8.1.1 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.1.2 BioCrea GmbH Product Introduction, Application and Specification
        • 8.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bristol-Myers Squibb Company
        • 8.2.1 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
        • 8.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Cerecor Inc.
        • 8.3.1 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.3.2 Cerecor Inc. Product Introduction, Application and Specification
        • 8.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Johnson & Johnson
        • 8.4.1 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Luc Therapeutics, Inc.
        • 8.5.1 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.5.2 Luc Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 NeurOp, Inc
        • 8.6.1 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.6.2 NeurOp, Inc Product Introduction, Application and Specification
        • 8.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Novartis AG
        • 8.7.1 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.7.2 Novartis AG Product Introduction, Application and Specification
        • 8.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 UCB S.A.
        • 8.8.1 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Production Sites and Area Served
        • 8.8.2 UCB S.A. Product Introduction, Application and Specification
        • 8.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Glutamate Receptor Ionotropic NMDA 2B Market

      • 9.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Trend Analysis
        • 9.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Glutamate Receptor Ionotropic NMDA 2B Regional Market Trend
        • 9.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
        • 9.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
        • 9.2.3 China Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
        • 9.2.4 Japan Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
        • 9.2.5 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
        • 9.2.6 India Glutamate Receptor Ionotropic NMDA 2B Forecast 2019-2025
      • 9.3 Glutamate Receptor Ionotropic NMDA 2B Market Trend (Product Type)
      • 9.4 Glutamate Receptor Ionotropic NMDA 2B Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Glutamate Receptor Ionotropic NMDA 2B Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Glutamate Receptor Ionotropic NMDA 2B . Industry analysis & Market Report on Glutamate Receptor Ionotropic NMDA 2B is a syndicated market report, published as Global Glutamate Receptor Ionotropic NMDA 2B Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Glutamate Receptor Ionotropic NMDA 2B market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,248.00
        4,872.00
        6,496.00
        545,510.00
        818,265.00
        1,091,020.00
        292,495.00
        438,742.50
        584,990.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report